XOMA (XOMAO) Competitors $25.38 +0.04 (+0.14%) Closing price 05/19/2026 03:58 PM EasternExtended Trading$25.38 0.00 (0.00%) As of 05/19/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock XOMAO vs. AIMDW, ALVOW, ARAV, ACABW, and RNAShould you buy XOMA stock or one of its competitors? MarketBeat compares XOMA with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with XOMA include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Avidity Biosciences (RNA). These companies are all part of the "pharmaceutical products" industry. XOMAO vs. AIMDWXOMAO vs. ALVOWXOMAO vs. ARAVXOMAO vs. ACABWXOMAO vs. RNAHow does XOMA compare to Ainos?XOMA (NASDAQ:XOMAO) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings, media sentiment and valuation. Does the media refer more to XOMAO or AIMDW? In the previous week, Ainos had 1 more articles in the media than XOMA. MarketBeat recorded 1 mentions for Ainos and 0 mentions for XOMA. XOMA's average media sentiment score of 0.00 equaled Ainos'average media sentiment score. Company Overall Sentiment XOMA Neutral Ainos Neutral Which has stronger valuation & earnings, XOMAO or AIMDW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioXOMA$7.65MN/AN/AN/AN/AAinos$18.11KN/AN/AN/AN/A Is XOMAO or AIMDW more profitable? Company Net Margins Return on Equity Return on Assets XOMAN/A N/A N/A Ainos N/A N/A N/A SummaryXOMA and Ainos tied by winning 1 of the 2 factors compared between the two stocks.How does XOMA compare to Alvotech?Alvotech (NASDAQ:ALVOW) and XOMA (NASDAQ:XOMAO) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, media sentiment, valuation, earnings, analyst recommendations, risk and profitability. Is ALVOW or XOMAO more profitable? Company Net Margins Return on Equity Return on Assets AlvotechN/A N/A N/A XOMA N/A N/A N/A Which has preferable valuation & earnings, ALVOW or XOMAO? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlvotech$586.32MN/AN/AN/AN/AXOMA$7.65MN/AN/AN/AN/A Does the media favor ALVOW or XOMAO? In the previous week, Alvotech's average media sentiment score of 0.00 equaled XOMA'saverage media sentiment score. Company Overall Sentiment Alvotech Neutral XOMA Neutral SummaryAlvotech beats XOMA on 1 of the 1 factors compared between the two stocks.How does XOMA compare to Aravive?Aravive (NASDAQ:ARAV) and XOMA (NASDAQ:XOMAO) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability, institutional ownership and media sentiment. Does the media prefer ARAV or XOMAO? In the previous week, Aravive's average media sentiment score of 0.00 equaled XOMA'saverage media sentiment score. Company Overall Sentiment Aravive Neutral XOMA Neutral Which has better earnings and valuation, ARAV or XOMAO? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAraviveN/AN/AN/A-$0.90N/AXOMA$7.65MN/AN/AN/AN/A Do institutionals and insiders hold more shares of ARAV or XOMAO? 35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is ARAV or XOMAO more profitable? Company Net Margins Return on Equity Return on Assets AraviveN/A N/A N/A XOMA N/A N/A N/A SummaryAravive beats XOMA on 2 of the 3 factors compared between the two stocks.How does XOMA compare to Atlantic Coastal Acquisition Corp. II?XOMA (NASDAQ:XOMAO) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, media sentiment, valuation and earnings. Is XOMAO or ACABW more profitable? Company Net Margins Return on Equity Return on Assets XOMAN/A N/A N/A Atlantic Coastal Acquisition Corp. II N/A N/A N/A Which has preferable earnings and valuation, XOMAO or ACABW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioXOMA$7.65MN/AN/AN/AN/AAtlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A Does the media prefer XOMAO or ACABW? In the previous week, XOMA's average media sentiment score of 0.00 equaled Atlantic Coastal Acquisition Corp. II'saverage media sentiment score. Company Overall Sentiment XOMA Neutral Atlantic Coastal Acquisition Corp. II Neutral SummaryXOMA beats Atlantic Coastal Acquisition Corp. II on 1 of the 1 factors compared between the two stocks.How does XOMA compare to Avidity Biosciences?XOMA (NASDAQ:XOMAO) and Avidity Biosciences (NASDAQ:RNA) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings. Does the media prefer XOMAO or RNA? In the previous week, Avidity Biosciences had 5 more articles in the media than XOMA. MarketBeat recorded 5 mentions for Avidity Biosciences and 0 mentions for XOMA. Avidity Biosciences' average media sentiment score of 0.80 beat XOMA's score of 0.00 indicating that Avidity Biosciences is being referred to more favorably in the news media. Company Overall Sentiment XOMA Neutral Avidity Biosciences Positive Is XOMAO or RNA more profitable? XOMA has a net margin of 0.00% compared to Avidity Biosciences' net margin of -3,650.39%. XOMA's return on equity of 0.00% beat Avidity Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets XOMAN/A N/A N/A Avidity Biosciences -3,650.39%-44.92%-39.57% Which has stronger earnings & valuation, XOMAO or RNA? XOMA has higher earnings, but lower revenue than Avidity Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioXOMA$7.65MN/AN/AN/AN/AAvidity Biosciences$36.68M6.04-$322.30MN/AN/A Do analysts prefer XOMAO or RNA? Avidity Biosciences has a consensus price target of $69.42, indicating a potential upside of 436.07%. Given Avidity Biosciences' stronger consensus rating and higher probable upside, analysts plainly believe Avidity Biosciences is more favorable than XOMA.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score XOMA 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Avidity Biosciences 1 Sell rating(s) 11 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.37 SummaryAvidity Biosciences beats XOMA on 7 of the 10 factors compared between the two stocks. Get XOMA News Delivered to You Automatically Sign up to receive the latest news and ratings for XOMAO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding XOMAO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XOMAO vs. The Competition ExportMetricXOMABiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$465.73M$6.25B$12.23BDividend Yield9.00%3.87%2.80%5.32%P/E RatioN/A3.7620.7925.05Price / SalesN/A7,435.94531.2172.69Price / CashN/A13.1343.0954.25Price / BookN/A83.539.816.83Net IncomeN/A-$96.07M$3.55B$335.69M7 Day Performance0.46%0.22%-2.12%-2.15%1 Month Performance0.22%0.83%-4.14%-2.47%1 Year Performance0.57%69.66%28.34%27.13% XOMA Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XOMAOXOMAN/A$25.39+0.1%N/A+0.3%$0.00$7.65MN/A10AIMDWAinosN/A$0.10+46.8%N/A-54.1%$0.00$124.16KN/A40News CoverageALVOWAlvotechN/A$0.20-2.8%N/A-89.2%$0.00$586.32MN/A4Gap UpARAVAraviveN/A$0.04flatN/AN/A$0.00N/AN/A20High Trading VolumeACABWAtlantic Coastal Acquisition Corp. IIN/A$0.00flatN/AN/A$0.00N/AN/A15 Related Companies and Tools Related Companies AIMDW Alternatives ALVOW Alternatives ARAV Alternatives ACABW Alternatives RNA Alternatives BFRIW Alternatives CALA Alternatives CELUW Alternatives CINGW Alternatives CMRAW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XOMAO) was last updated on 5/20/2026 by MarketBeat.com Staff. From Our PartnersI’m sounding the alarmMeta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...Porter & Company | SponsoredYour book attachedVeteran trader Bill Poulos is giving away his 'Simple Options Trading For Beginners' book - normally $29.97 - ...Profits Run | SponsoredThe one number Musk can't hide in the S-1When SpaceX files its S-1 in June, one number will stand out - power consumption. Running 1 million GPUs requi...Behind the Markets | SponsoredHe doesn't buy gold. He just profits from it.Former hedge fund manager Larry Benedict generated $274 million in profits - and Barron's ranked his fund in t...Brownstone Research | SponsoredHow to Access Elon’s “Monster” Interest RateMost Americans earn just 0.4% on their savings - that's $40 a year on $10,000. A new banking alternative is of...InvestorPlace | SponsoredThe “tell” for the end of the AI boomThe real question about AI stocks in 2026 isn't whether to own them - it's knowing exactly when to get in and ...Stansberry Research | SponsoredBIGGER than the SpaceX IPO?Jon Najarian believes the SpaceX IPO - potentially arriving as soon as June 12th - may not even be the biggest...Banyan Hill Publishing | SponsoredAfter June 1, don't say I didn't warn youMacroeconomic Strategist Dr. Mark Skousen of The Oxford Club says one date should be at the top of every inves...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XOMA Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share XOMA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
